- Projects & figures
- News & Events
- Managing your project
- About ERC
Over the past months, a sudden influx of ‘Pokémon Go’ players could be observed across the globe. Youngsters, people of all ages scrutinise their surroundings silently, using their smartphones to catch those digital creatures with unlikely names. How could such a phenomenon take over the world so fast? Part of the answer may be the game’s strong interaction with the real-world and its impressive mapping, offering a whole new virtual experience of spaces that seem to be familiar and yet so different.
More than 3.5 million new people are diagnosed with heart failure every year in Europe, with a long-term prognosis of 50% mortality within four years. There is urgent need for more innovative, regenerative therapies with the potential to change the course of the condition.
For millions of young people around the world migration is part of their biographies. Yet we know very little about their mobility throughout their young lives because we’ve focused on just two types of moves: their first move to a new country of residence, or their parents’ migration. Prof. Mazzucato will be trying to understand the mobility patterns of youth with migrant backgrounds and how mobility affects youth's life chances. And she is the ERC's 500th grantee in the Netherlands.
Living creatures relate to their surroundings in all kinds of ways. One of these is by eating from them and excreting into them. But what is eating? Incorporating other creatures or absorbing nutrients? A need of individual bodies or a pleasure that table companions share? The ERC project EATINGBODIES has explored such questions by studying various forms of eating.
The starting point of this research project is the disproportionality between the alleged “crime” of being an undocumented migrant and the sanction of deportation. But what determines the ways in which deportation is being implemented on the ground? What are the factors that prevent or expedite implementation?
Acetylsalicylic acid, most commonly known as aspirin, was already part of the Egyptian pharmacopeia, used also in ancient Greece and in the Middle Ages to break fevers. Taken all over the world to kill pain and reduce inflammation, today aspirin helps to prevent heart attacks, strokes and blood clots. Its emerging role in preventing and treating cancer is on the rise too. But how does this drug act on your blood cells? ERC grantee Prof Valerie O’Donnell works on the answer.
A ground-breaking anthropological discovery took place in East Africa, where ERC Advanced grantee Dr Marta Mirazón Lahr and her team have been studying human origins. At the excavation site in Nataruk in northern Kenya, they have stumbled upon a real archaeological rarity – the earliest historical evidence of warfare.
How close are we to developing a successful and comprehensive vaccine for cancer? ERC grantee Prof. Yvette van Kooyk thinks that a combination of glycobiology and immunology will lead us closer than ever before. Thanks to her ground-breaking multidisciplinary team and her new approach based on sugar receptors, she has developed a nanovaccine that promises to represent the future for cancer treatment.
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to bring new insight into pregnancy-associated malaria, to save the lives of women and their babies in areas affected by the disease. Now, Dr Salanti’s research has shifted to battling against another deadly disease: cancer. This comes after an unexpected discovery yielded ground-breaking results for the diagnosis and treatment of this illness. This is the kind of curiosity-driven research that can lead to ground-breaking serendipitous outcomes.